Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Glen Santangelo will join the firm in January as a Managing Director in a planned expansion of the firm’s Healthcare Research team. Mr. Santangelo will focus on the coverage of Healthcare IT and Distribution companies in close collaboration with the growing therapeutics and services team.
Venture Strategy Identifies Promising, Early-Stage Organizations Using Innovative Solutions to Solve Enduring Social Problems
Guggenheim Investments warns that factors that have contributed to strong earnings growth this year will fade in 2019 and turn into headwinds in 2020, leaving heavily leveraged corporate borrowers dangerously exposed.
Guggenheim Partners Executive Chairman Alan Schwartz joins Bloomberg TV to highlight risks for the markets and where CEOs should focus for the long term.
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that four senior research professionals have joined the firm’s Technology, Media, and Telecom (TMT) equity research practice.
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that it completed its previously announced acquisition of Millstein & Co., a leading advisor to companies, investors, governments and other stakeholders facing complex financial issues, including providing advice on restructuring, mergers and acquisitions and liability management transactions.
From July 9 – 27, Guggenheim Partners hosted its second-annual Guggenheim Community Impact (GCI), the firm’s Corporate Social Responsibility (CSR) summer volunteer campaign.
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Matthew Brogdon has joined the firm as a Senior Managing Director in the firm’s Houston-based Oil and Gas investment banking group.
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Yatin Suneja will join the firm in November as a Managing Director, continuing the firm’s planned expansion of the Healthcare Research team. Mr. Suneja will focus on the coverage of Biotechnology companies in close collaboration with our growing therapeutics team.
While the U.S. economy remains on solid footing, trade war risk, a flattening yield curve and other factors signal recession ahead and warrant portfolio changes.
You are now leaving this website.Guggenheim assumes no responsibility of the content or its accuracy.